Skip to main content
Loading market data...
ETF NYSE Arca USD

iShares Genomics Immunology and Healthcare ETF IDNA

Issuer: iShares SEC registrant: iShares Trust Equity · Global
Last price 42.05 USD Change: Up +1.09 Percent change: Up +2.66%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.47%
Prospectus 28 Nov 2025
Net assets
$190.9M
As of 31 Jul 2026
Holdings
61
As of 31 Jul 2026
12-month distribution yield
0.67%
Twice a year
Asset class
Equity
From holdings

iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund listed on NYSE Arca in the United States, issued by iShares. Its category is Equity · Global (equity). Its last price was US$42.05 on 20 Oct 2026. Its expense ratio is 0.47% a year, from its prospectus dated 28 Nov 2025. It reported net assets of US$190.86 million as of 31 Jul 2026. Its latest holdings report lists 61 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.28 a unit, a 12-month distribution yield of 0.67%, paid twice a year.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.47%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.47%
Prospectus date
28 Nov 2025
Filed with the SEC
21 Nov 2025

Size and reporting

Net assets
$190,862,668
Total assets
$210,785,506
Holdings as of
31 Jul 2026
Report made public
23 Sep 2026 (54 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 61 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

IDNA top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY US0669225197 10.39% $19.8M Short-term investment vehicles (cash funds) United States USD
2 Bayer Aktiengesellschaft BAYER AG DE000BAY0017 4.81% $9.2M Equity (common) Germany EUR
3 Twist Bioscience Corp US90184D1000 4.79% $9.1M Equity (common) United States USD
4 REVOLUTION MEDICINES, INC. US76155X1000 4.55% $8.7M Equity (common) United States USD
5 REGENERON PHARMACEUTICALS, INC. US75886F1075 4.35% $8.3M Equity (common) United States USD
6 GENMAB A/S DK0010272202 4.23% $8.1M Equity (common) Denmark DKK
7 INCYTE CORPORATION US45337C1027 4.23% $8.1M Equity (common) United States USD
8 MODERNA, INC. US60770K1079 4.19% $8.0M Equity (common) United States USD
9 Takeda Pharmaceutical Company Limited TAKEDA PHARMACEUTICAL CO LTD JP3463000004 4.05% $7.7M Equity (common) Japan JPY
10 MERCK & CO., INC. US58933Y1055 3.91% $7.5M Equity (common) United States USD
11 VERTEX PHARMACEUTICALS INCORPORATED US92532F1003 3.87% $7.4M Equity (common) United States USD
12 Roche Holding AG CH1499059983 3.85% $7.3M Equity (common) Switzerland CHF
13 IPSEN SA FR0010259150 3.84% $7.3M Equity (common) France EUR
14 BioNTech SE US09075V1026 3.73% $7.1M Other Germany USD
15 EXELIXIS, INC. US30161Q1040 3.65% $7.0M Equity (common) United States USD
16 GSK PLC GB00BN7SWP63 3.63% $6.9M Equity (common) United Kingdom GBP
17 SANOFI SA FR0000120578 3.46% $6.6M Equity (common) France EUR
18 IDEAYA Biosciences Inc US45166A1025 3.36% $6.4M Equity (common) United States USD
19 Immunitybio Inc US45256X1037 3.07% $5.9M Equity (common) United States USD
20 ARCUS BIOSCIENCES, INC. US03969F1093 2.68% $5.1M Equity (common) United States USD
21 CARIS LIFE SCIENCES, INC. US1421521071 2.18% $4.2M Equity (common) United States USD
22 ONO PHARMACEUTICAL CO., LTD. JP3197600004 1.91% $3.7M Equity (common) Japan JPY
23 Iovance Biotherapeutics Inc US4622601007 1.80% $3.4M Equity (common) United States USD
24 NUVATION BIO INC. US67080N1019 1.78% $3.4M Equity (common) United States USD
25 CRISPR Therapeutics AG CH0334081137 1.57% $3.0M Equity (common) Switzerland USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 96.02%
Short-term investment vehicles (cash funds) 10.49%
Other 3.81%
Equity derivatives 0.01%

Country

Country by weight
CountryWeightBar
United States 70.15%
Germany 8.54%
France 7.76%
Japan 6.00%
Switzerland 5.41%
Denmark 4.24%
United Kingdom 3.66%
China 2.26%
Canada 1.52%
Luxembourg 0.53%
South Korea 0.25%
Hong Kong <0.01%
Other (2) <0.01%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 77.49%
Euro (EUR) 12.57%
Japanese yen (JPY) 6.00%
Danish krone (DKK) 4.24%
Swiss franc (CHF) 3.85%
British pound (GBP) 3.66%
Hong Kong dollar (HKD) 2.27%
South Korean won (KRW) 0.25%
New Taiwan dollar (TWD) <0.01%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 39.82%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.2800
2 payments per unit
12-month yield
0.67%
Distributions only, not total return
Frequency
Twice a year
From the gaps between ex-dates
Latest ex-date
15 Jun 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.2800) ÷ latest price ($42.05) × 100 = 0.67%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (9 payments)
IDNA distributions per unit by ex-date
Ex-dateAmount per unit
15 Jun 2026$0.1250
16 Dec 2025$0.1550
16 Jun 2025$0.1530
17 Dec 2024$0.1110
11 Jun 2024$0.1110
20 Dec 2023$0.1690
7 Jun 2023$0.0710
9 Jun 2022$0.1360
13 Dec 2021$0.2560

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme